Tumor immunity can be reprogrammed through the mobilization and infiltration of various subfamilies of immune cells, such as CD8+ T cells and Natural Killer (NK) cells, into tumor cells and the TME [21,22]. This evidence concerns the gene CD8A and neoplasm.